Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Chin · SciRah

Researcher profile · Semantic Scholar

K. Chin

Share profile

K. Chin — researcher profile on SciRah

h-index: 41
Works: 304
Citations: 10K

Most-cited papers

Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial.
Yasuhide Yamada, N. Boku, J. Mizusawa, S. Iwasa +16 more
2019The Lancet Gastroenterology and Hepatology109 citations
Semantic Scholar
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
N. Boku, T. Satoh, M. Ryu, Y. Chao +21 more
2021Gastric Cancer104 citations Open access
Semantic Scholar
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
Yoon-Koo Kang, K. Chin, H. Chung, S. Kadowaki +15 more
2020The Lancet Oncology68 citations Open access
Semantic Scholar
Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival
Y. Ota, D. Takahari, Takeshi Suzuki, H. Osumi +9 more
2020Cancer Chemotherapy and Pharmacology68 citations
Semantic Scholar
A Single-Arm Confirmatory Study of Definitive Chemoradiotherapy Including Salvage Treatment for Clinical Stage II/III Esophageal Squamous Cell Carcinoma (JCOG0909 Study).
H. Takeuchi, Y. Ito, R. Machida, Ken Kato +16 more
2022International Journal of Radiation Oncology, Biology, Physics64 citations
Semantic Scholar
Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer
D. Takahari, K. Chin, N. Ishizuka, A. Takashima +13 more
2019Gastric Cancer52 citations Open access
Semantic Scholar
TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma
H. Bando, D. Kotani, T. Tsushima, H. Hara +14 more
2020BMC Cancer51 citations Open access
Semantic Scholar
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
Masanobu Takahashi, Ken Kato, M. Okada, K. Chin +14 more
2020Esophagus45 citations Open access
Semantic Scholar
Three-Year Follow-Up and Response–Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3)
M. Okada, Ken Kato, B. Cho, Masanobu Takahashi +15 more
2022Clinical Cancer Research37 citations Open access
Semantic Scholar
Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy
R. Takahashi, M. Ohashi, Yosuke Kano, S. Ida +7 more
2019Gastric Cancer36 citations Open access
Semantic Scholar
Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia
T. Yoshikawa, K. Muro, K. Shitara, D. Oh +15 more
2019JAMA Network Open35 citations Open access
Semantic Scholar
Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma
Takeshi Suzuki, A. Okamura, Masayuki Watanabe, S. Mine +10 more
2019Annals of Surgical Oncology27 citations
Semantic Scholar
Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma
A. Ooki, H. Osumi, K. Chin, Masayuki Watanabe +1 more
2023Therapeutic Advances in Medical Oncology25 citations Open access
Semantic Scholar
Long‐term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a‐muscularis mucosae and T1b‐submucosa by endoscopic resection followed by appropriate additional treatment
S. Naito, Toshiyuki Yoshio, A. Ishiyama, T. Tsuchida +14 more
2021Digestive Endoscopy25 citations
Semantic Scholar
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study
Yoon-Koo Kang, S. Morita, T. Satoh, M. Ryu +22 more
2021Gastric Cancer21 citations Open access
Semantic Scholar
A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer
H. Osumi, A. Takashima, A. Ooki, Yuri Yoshinari +17 more
2023Translational Oncology19 citations Open access
Semantic Scholar
Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer
H. Osumi, E. Shinozaki, A. Ooki, K. Shimozaki +7 more
2021Cancer Medicine19 citations Open access
Semantic Scholar
Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma: A Comparison of Outcomes between Esophagectomy and Chemoradiotherapy
Y. Kanie, A. Okamura, T. Asari, S. Maruyama +9 more
2021Annals of Surgical Oncology19 citations
Semantic Scholar
Efficacy of trastuzumab emtansine in Japanese patients with previously treated HER2‐positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: A subgroup analysis of the GATSBY study
K. Shitara, Y. Honma, Y. Omuro, K. Yamaguchi +6 more
2019Asia-Pacific Journal of Clinical Oncology18 citations
Semantic Scholar
Effect of neutropenia on survival outcomes of patients with metastatic colorectal cancer receiving trifluridine/tipiracil plus bevacizumab
D. Kamiimabeppu, H. Osumi, E. Shinozaki, A. Ooki +8 more
2021Oncology Letters16 citations Open access
Semantic Scholar
Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer
Yasuhide Yamada, W. Koizumi, K. Nishikawa, M. Gotoh +16 more
2019Cancer Science16 citations Open access
Semantic Scholar
KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer
K. Shimozaki, E. Shinozaki, N. Yamamoto, Y. Imamura +9 more
2022Journal of Cancer Research and Clinical Oncology15 citations Open access
Semantic Scholar
Nivolumab versus chemotherapy in advanced esophageal squamous cell carcinoma (ESCC): The phase III ATTRACTION-3 study
B. Cho, K. Kato, Masahiro Takahashi, M. Okada +14 more
2019Annals of Oncology15 citations Open access
Semantic Scholar
Safety and tolerability of andecaliximab as monotherapy and in combination with an anti-PD-1 antibody in Japanese patients with gastric or gastroesophageal junction adenocarcinoma: a phase 1b study
Akie Kimura Yoshikawa, K. Yamaguchi, K. Muro, A. Takashima +12 more
2022Journal for ImmunoTherapy of Cancer14 citations Open access
Semantic Scholar
1211P A multicenter phase II study of atezolizumab monotherapy following definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma (EPOC1802)
H. Bando, S. Kumagai, D. Kotani, M. Saori +16 more
2022Annals of Oncology14 citations Open access
Semantic Scholar
A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care
K. Shimozaki, I. Nakayama, D. Takahari, D. Kamiimabeppu +7 more
2021ESMO Open13 citations Open access
Semantic Scholar
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers
K. Kobayashi, E. Sugiyama, E. Shinozaki, T. Wakatsuki +21 more
2021Cancer Chemotherapy and Pharmacology13 citations
Semantic Scholar
Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibitors as second‐line chemotherapy
H. Osumi, E. Shinozaki, A. Ooki, T. Wakatsuki +7 more
2020Cancer Medicine13 citations Open access
Semantic Scholar
Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer
Takeshi Suzuki, E. Shinozaki, H. Osumi, I. Nakayama +9 more
2019Cancer Chemotherapy and Pharmacology13 citations
Semantic Scholar
Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases
K. Yoshino, H. Osumi, Hiromichi Ito, D. Kamiimabeppu +14 more
2022Annals of Surgical Oncology12 citations
Semantic Scholar
Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists
Yosuke Kano, M. Ohashi, N. Hiki, D. Takahari +6 more
2020Surgery today (Print)12 citations
Semantic Scholar
Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807
T. Ura, S. Hironaka, Y. Tsubosa, J. Mizusawa +13 more
2022Esophagus11 citations
Semantic Scholar
Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer
H. Udagawa, S. Takahashi, M. Hirao, M. Tahara +12 more
2022Cancer Medicine11 citations Open access
Semantic Scholar
The association of primary tumor site with acute adverse event and efficacy of definitive chemoradiotherapy for cStage II/III esophageal cancer: an exploratory analysis of JCOG0909
S. Hironaka, A. Komori, R. Machida, Y. Ito +14 more
2020Esophagus11 citations
Semantic Scholar
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research
D. Takahari, E. Shinozaki, T. Wakatsuki, A. Ooki +10 more
2020International Journal of Clinical Oncology11 citations Open access
Semantic Scholar
A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma
A. Ooki, T. Satoh, K. Muro, A. Takashima +12 more
2022Scientific Reports10 citations Open access
Semantic Scholar
Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy.
Yosuke Kano, M. Ohashi, Y. Muneoka, D. Takahari +7 more
2021European Journal of Surgical Oncology10 citations
Semantic Scholar
Clinical Impact of Primary Tumor Location and RAS, BRAF V600E, and PIK3CA Mutations on Epidermal Growth Factor Receptor Inhibitor Efficacy as Third-line Chemotherapy for Metastatic Colorectal Cancer
Taro Sato, H. Osumi, E. Shinozaki, A. Ooki +8 more
2021Anticancer Research10 citations Open access
Semantic Scholar
Esophageal cancer patients' survival after complete response to definitive chemoradiotherapy: a retrospective analysis
K. Mori, K. Sugawara, S. Aikou, H. Yamashita +8 more
2021Esophagus10 citations
Semantic Scholar
Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study
Y. Kitagawa, H. Osumi, E. Shinozaki, Y. Ota +9 more
2020BMC Cancer10 citations Open access
Semantic Scholar
Efficacy and Safety of Self-Expandable Metallic Stent Placement for Malignant Esophageal Fistula
Atsuko Izumi, Toshiyuki Yoshio, Takashi Sasaki, Mitsuaki Ishioka +12 more
2023Journal of Clinical Medicine9 citations Open access
Semantic Scholar
Effect of DNA methylation status on first-line anti-epidermal growth factor receptor treatment in patients with metastatic colorectal cancer
H. Osumi, K. Ouchi, E. Shinozaki, S. Takahashi +8 more
2022International Journal of Colorectal Disease9 citations
Semantic Scholar
Three-year follow-up of ATTRACTION-3: A phase III study of nivolumab (Nivo) in patients with advanced esophageal squamous cell carcinoma (ESCC) that is refractory or intolerant to previous chemotherapy.
K. Chin, Ken Kato, B. Cho, Masanobu Takahashi +15 more
20219 citations
Semantic Scholar
A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study
M. Suenaga, T. Wakatsuki, T. Mashima, M. Ogura +9 more
2019Investigational new drugs9 citations
Semantic Scholar
Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018
I. Nakayama, D. Takahari, K. Shimozaki, K. Chin +7 more
2022The Oncologist8 citations Open access
Semantic Scholar
Safety and early efficacy results of a phase Ib study of nivolumab plus trastuzumab with S-1/capecitabine plus oxaliplatin for HER2-positive advanced gastric cancer (Ni-HIGH study).
D. Takahari, H. Shoji, K. Minashi, H. Hara +11 more
2022Journal of Clinical Oncology8 citations
Semantic Scholar
The Combined Use of 5 or More Drugs Is a Factor Related to Lower Adherence to S-1 in S-1 and Oxaliplatin Treatment for Advanced Gastric Cancer.
K. Kawakami, T. Aoyama, T. Yokokawa, K. Kobayashi +6 more
2021Biological and Pharmaceutical Bulletin8 citations Open access
Semantic Scholar
Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3
K. Chin, S. Yamamoto, Masanobu Takahashi, S. Kadowaki +8 more
2022Esophagus7 citations Open access
Semantic Scholar
Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer
D. Kamiimabeppu, T. Wakatsuki, D. Takahari, N. Fukuda +8 more
2022International Journal of Clinical Oncology7 citations
Semantic Scholar
Safety and Efficacy of Self-Expandable Metallic Stent Placement Using Low Radial Force Stent for Malignant Dysphagia after Radiotherapy
Mitsuaki Ishioka, Toshiyuki Yoshio, Takashi Sasaki, Atsuko Tamashiro +13 more
2022Digestion7 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Yamaguchi×30
Invite
K. Yamaguchi — researcher profile on SciRah
D. Takahari×23
Invite
D. Takahari — researcher profile on SciRah
M. Ogura×23
Invite
M. Ogura — researcher profile on SciRah
I. Nakayama×19
Invite
I. Nakayama — researcher profile on SciRah

×18

Invite

H. Osumi — researcher profile on SciRah

T. Wakatsuki×18

Invite

T. Wakatsuki — researcher profile on SciRah

Invite

A. Ooki — researcher profile on SciRah

E. Shinozaki×17

Invite

E. Shinozaki — researcher profile on SciRah

S. Kadowaki×13

Invite

S. Kadowaki — researcher profile on SciRah

Invite

Ken Kato — researcher profile on SciRah

Invite

N. Boku — researcher profile on SciRah

D. Kamiimabeppu×9

Invite

D. Kamiimabeppu — researcher profile on SciRah